Clinical trials
Phase 1 Dermatomyositis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 4 |
| AstraZeneca | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Zhejiang University | 1 |
| iCell Gene Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatomyositis | 8 |
| Arthritis, Juvenile | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Myositis | 2 |
| Polymyositis | 2 |
| Scleroderma, Systemic | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Arthritis | 1 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.